Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Mathew, Nimitha R; Baumgartner, Francis; Braun, Lukas; O'Sullivan, David; Thomas, Simone; Waterhouse, Miguel; Müller, Tony A; Hanke, Kathrin et al. · Nat Med · 2018

editorial · Level V

Where this comes from

Record sourced from PubMed, PMID 29634689.
Also identified by DOI 10.1038/nm0418-526c.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

This corrects the article DOI: 10.1038/nm.4484.

Read the full text

View on PubMed · Publisher (DOI)